Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND It has long been believed that DHA supplementation increases plasma EPA via the retroconversion pathway in mammals. However, in rodents this increase in EPA is likely due to a slower metabolism of EPA, but this has never been tested directly in humans. OBJECTIVE The aim of this study was to use the natural variations in 13C:12C ratio (carbon-13 isotopic abundance [δ13C]) of n-3 PUFA supplements to assess n-3 PUFA metabolism following DHA or EPA supplementation in humans. METHODS Participants (aged 21.6 ± 2.2 y) were randomly assigned into 1 of 3 supplement groups for 12 wk: 1) olive oil control, 2) ∼3 g/d DHA, or 3) ∼3 g/d EPA. Blood was collected before and after the supplementation period, and concentrations and δ13C of plasma n-3 PUFA were determined. RESULTS DHA supplementation increased (P < 0.05) plasma EPA concentrations by 130% but did not affect plasma δ13C-EPA (-31.0 ± 0.30 to -30.8 ± 0.19, milliUrey ± SEM, P > 0.05). In addition, EPA supplementation did not change plasma DHA concentrations (P > 0.05) but did increase plasma δ13C-DHA (-27.9 ± 0.2 to -25.6 ± 0.1, P < 0.05) toward δ13C-EPA of the supplement (-23.5 ± 0.22). EPA supplementation increased plasma concentrations of EPA and docosapentaenoic acid (DPAn-3) by 880% and 200%, respectively, and increased plasma δ13C-EPA (-31.5 ± 0.2 to -25.7 ± 0.2) and δ13C-DPAn-3 (-28.9 ± 0.3 to -25.0 ± 0.1) toward δ13C-EPA of the supplement. CONCLUSIONS In this study, we show that the increase in plasma EPA following DHA supplementation in humans does not occur via retroconversion, but instead from a slowed metabolism and/or accumulation of plasma EPA. Furthermore, substantial amounts of supplemental EPA can be converted into DHA. δ13C of n-3 PUFA in humans is a powerful and underutilized tool that can track dietary n-3 PUFA and elucidate complex metabolic questions. This trial was registered at clinicaltrials.gov as NCT03378232.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distribution, interconversion, and dose response of n-3 fatty acids in humans.
Arterburn, L. M., Hall, E. B., & Oken, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1467s · Cited by 1,162
Burdge, G. C., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002689 · Cited by 812
Assessment of international reference materials for isotope-ratio analysis (IUPAC Technical Report)
Brand, W. A., Coplen, T. B., Vogl, J., Rosner, M., & Prohaska, T. (2014) · Pure and Applied Chemistry · doi:10.1515/pac-2013-1023 · Cited by 704 · cited 1×
“to the carbonaceous remains of a Cretaceous marine fossil, Belemnitella americana (21), containing a high δ13C value that is characteristic of carbonates.”
BackgroundBurdge, G. C., Jones, A. E., & Wootton, S. A. (2002) · British Journal Of Nutrition · doi:10.1079/bjn2002662 · Cited by 598
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
Woodman, R. J., Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., & Beilin, L. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1007 · Cited by 338
Grimsgaard, S., Bonaa, K., Hansen, J., & Nordøy, A. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.3.649 · Cited by 300
Nestel, P., Shige, H., Pomeroy, S., Cehun, M., Abbey, M., & Raederstorff, D. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.326 · Cited by 263
Conquer, J. A., & Holub, B. J. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.12.3032 · Cited by 181 · cited 1×
“Retroconversion of DHA to EPA is thought to occur in rodents (28, 29) and humans (25, 28, 30), and has long been postulated as the mechanism responsible for the described increases in EPA with DHA feeding.”
Background
Cited by
So, J., Wu, D., Lichtenstein, A. H., Tai, A. K., Matthan, N. R., Maddipati, K. R., & Lamon-Fava, S. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.018 · Cited by 127
Klingel, S. L., Metherel, A. H., Irfan, M., Rajna, A., Chabowski, A., Bazinet, R. P., & Mutch, D. M. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz234 · Cited by 54
Self-citationMaki, K. C., Bays, H. E., Ballantyne, C. M., Underberg, J. A., Kastelein, J. J. P., Johnson, J. B., Ferguson, J. J., Bays, H., Blomer, A., Kelley, K., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024176 · Cited by 12
Alteration of Fatty Acid Profile in Fragile X Syndrome
Abolghasemi, A., Carullo, M. P., Aguilera, E. C., Laroui, A., Plantefeve, R., Rojas, D., Benachenhou, S., Ramírez, M. V., Proteau-Lemieux, M., Lepage, J.-F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810815 · Cited by 6
“Considering the important roles of both these FAs as well as the fact that the majority content of EPA can be converted into DHA [47], we hypothesize that a supplementation formula with a higher EPA content than DHA might be more effective in the treatment of neurodevelopmental disorders, including FXS.”
Background
Metadata
- Authors
- Metherel, A. H., Irfan, M., Klingel, S. L., Mutch, D. M., & Bazinet, R. P.
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 110
- Issue
- 4
- Pages
- 823-831
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2952928229
- Cited by
- 97
- References
- 9
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial. https://app.cochat.ai/papers/10.1093/ajcn/nqz097
- The paper
- Metherel, A. H., Irfan, M., Klingel, S. L., Mutch, D. M., & Bazinet, R. P. (2019). Compound-specific isotope analysis reveals no retroconversion of DHA to EPA but substantial conversion of EPA to DHA following supplementation: a randomized control trial. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/nqz097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.